The common genetic mutations and altered oncogene or tumor suppressor gene expression, as well as signal transduction alterations (including N-ras, p53, Rb, and p16 cyclin dependent kinase aberrations), have been reported to occur similarly in human lymphomas as well as in dogs [14,56,57]. This evidence concerns the gene CDKN2A and lymphoma.